Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
18 December 2020
PHF6 Expression Levels Impact Human Hematopoietic Stem Cell Differentiation
4 November 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
9 July 2020
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
30 June 2020
A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models
26 June 2020
Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development
7 April 2020
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review
1 February 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
14 January 2020
SMARTer single cell total RNA sequencing
19 September 2019
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
5 April 2019
Purification of high-quality RNA from a small number of fluorescence activated cell sorted zebrafish cells for RNA sequencing purposes
20 March 2019
DREAM target reactivation by core transcriptional regulators supports neuroblastoma growth
3 February 2019
Long noncoding RNA expression profiling in cancer: Challenges and opportunities
20 January 2019
ALK positively regulates MYCN activity through repression of HBP1 expression
11 December 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
7 December 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
6 December 2018
In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
30 November 2018
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
20 November 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
19 November 2018
A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing
28 June 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
15 June 2018
Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia
18 April 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
5 March 2018
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease
2 February 2018
Epigenetic regulation of neuroblastoma development
2 February 2018
Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome
5 December 2017
Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients
14 July 2017
T-ALL and thymocytes: a message of noncoding RNAs
7 March 2017
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait
6 September 2016
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia
10 May 2016
Neuroblastoma: A Tough Nut to Crack
1 January 2016
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
15 July 2015
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
